ARCHIVES

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

This article is from The Cancer Letter archive.

Vol. 04 No. 20 | May 19, 1978

Download PDF Visit The Full Archive

Related Articles

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort

October 8, 1993

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012